The Total revenue for the quarter ended September 2021 of  Rs. 670.03 millions remain, more or less, the same.Handsome Net Profit growth of 99.93% reported above the corresponding previous quarter figure of Rs. 30.55 millions to Rs. 15.28 millions.Operating profit for the quarter ended September 2021 decreased to 73.17 millions as compared to 78.02 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202003 201903 % Var
Sales 670.03 642.76 4.24 3166.38 2870.02 10.33 1706.73 2230.79 -23.49
Other Income 9.11 3.93 131.81 29.57 44.89 -34.13 36.15 27.46 31.65
PBIDT 73.17 78.02 -6.22 358.21 238.80 50.00 98.74 230.54 -57.17
Interest 25.77 31.66 -18.60 143.83 183.64 -21.68 124.16 125.29 -0.90
PBDT 47.40 46.36 2.24 214.38 55.16 288.65 -25.42 105.25 -124.15
Depreciation 17.15 18.01 -4.78 83.39 103.21 -19.20 70.27 61.15 14.91
PBT 30.25 28.35 6.70 130.99 -48.05 -372.61 -95.69 44.10 -316.98
TAX -0.30 13.07 -102.30 31.78 15.57 104.11 -0.41 -23.49 -98.25
Deferred Tax 0.00 0.00 0.00 -2.48 0.00 0.00 0.00 0.00 0.00
PAT 30.55 15.28 99.93 99.21 -63.62 -255.94 -95.28 67.59 -240.97
Equity 148.22 141.72 4.59 148.22 141.72 4.59 141.72 141.72 0.00
PBIDTM(%) 10.92 12.14 -10.03 11.31 8.32 35.96 5.79 10.33 -44.02

Bal Pharma Share Price

68.50 -0.69 (-1.00%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×